Results 11 to 20 of about 25,256 (244)
A case of rhabdomyolysis in which levetiracetam was suspected as the cause
Epilepsy & Behavior Case Reports, 2014 Several studies have reported rhabdomyolysis induced by various drugs but not by the antiepileptic drug levetiracetam. We present a case of suspected levetiracetam-induced rhabdomyolysis.
Yasuhiro Hasegawa +2 more
exaly +3 more sources
Treatment Patterns of Antiseizure Medication for Poststroke Prophylaxis Among Older Adults [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Antiseizure medications are commonly prescribed for poststroke seizures, yet long‐term use lacks clear clinical guidance. We examined medication treatment patterns among older adults who initiated levetiracetam, the most frequently prescribed ...
Shuo Sun +6 more
doaj +2 more sources
Journal of Pain and Symptom Management, 2018 Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).
Paul, Howard +8 more
+5 more sources
Levetiracetam Therapeutic Drug Monitoring in a Large Cohort of Korean Epileptic Patients
Pharmaceuticals, 2021 Levetiracetam is a new antiepileptic drug (AED) used for treating and preventing partial or generalized seizures. The usefulness of levetiracetam therapeutic drug monitoring (TDM) is related to inter- or intra-individual pharmacokinetic variability, drug
Changhee Ha +6 more
doaj +1 more source
Levetiracetam-Induced Pancytopenia in an HIV Seropositive Patient With SARS-CoV-2
Annals of Internal Medicine: Clinical Cases, 2022 Levetiracetam is a widely used and safe antiepileptic drug, and levetiracetam-induced pancytopenia is an uncommon adverse effect. We present a patient case of a middle-aged man with seizures who developed profound pancytopenia within 4 days of starting ...
Lemchukwu Chukwunonye Amaeshi +4 more
doaj +1 more source
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam
Therapeutic Advances in Drug Safety, 2022 Some old antiseizure medications (ASMs) pose teratogenic risks, including major congenital malformations and neurodevelopmental delay. Therefore, the use of new ASMs in pregnancy is increasing, particularly lamotrigine and levetiracetam.
Bshra A. Alsfouk
doaj +1 more source
Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
Palliative Medicine Reports, 2021 We report on a patient suffering from seizures caused by cerebral metastases of adenocarcinoma of the lung. Initially, the patient was treated effectively with oral levetiracetam. As the disease progressed, oral intake was no longer possible.
Sophia Westphal +3 more
doaj +1 more source
Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
Respiratory Medicine Case Reports, 2020 An 85-year-old woman with antibiotics-resistant pneumonia after surgery for metastatic brain tumor from lung cancer was consulted to our department. Chest CT showed diffuse GGO bilaterally. BALF showed elevated ratios of lymphocytes and CD4/CD8.
Shintaro Sato +12 more
doaj +1 more source
Levetiracetam-induced rage and suicidality: Two case reports and review of literature
Epilepsy and Behavior Case Reports, 2015 Background: Levetiracetam-induced rage is a rare neurobehavioral adverse effect of levetiracetam that is characterized by seething rage, uncontrollable anger, fits of fury, depression, violence, and suicidal tendencies.
Orakwue A. Molokwu +2 more
doaj +1 more source
Intravenous levetiracetam for treatment of seizures in term and preterm neonates
Journal of Pediatric Neurosciences, 2020 Context: Seizures are the most frequent neurological disturbance in the neonatal period, and there are no evidence-based guidelines for the treatment of neonatal seizures.
Pakize Karaoglu +6 more
doaj +1 more source